Pharmacodynamics of ceftazidime plus the serine beta-lactamase inhibitor AM-112 against Escherichia coli containing TEM-1 and CTX-M-1 beta-lactamases.
about
Will new antimicrobials overcome resistance among Gram-negatives?Combating multidrug-resistant Gram-negative bacterial infections.The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection.
P2860
Pharmacodynamics of ceftazidime plus the serine beta-lactamase inhibitor AM-112 against Escherichia coli containing TEM-1 and CTX-M-1 beta-lactamases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacodynamics of ceftazidim ...... 1 and CTX-M-1 beta-lactamases.
@en
type
label
Pharmacodynamics of ceftazidim ...... 1 and CTX-M-1 beta-lactamases.
@en
prefLabel
Pharmacodynamics of ceftazidim ...... 1 and CTX-M-1 beta-lactamases.
@en
P2093
P2860
P1476
Pharmacodynamics of ceftazidim ...... 1 and CTX-M-1 beta-lactamases.
@en
P2093
Alan R Noel
Alasdair P MacGowan
Chris A Rogers
Karen E Bowker
P2860
P304
P356
10.1128/AAC.48.11.4482-4484.2004
P407
P577
2004-11-01T00:00:00Z